Open Interest and Volume Dynamics
The latest data reveals that Lupin’s open interest (OI) in derivatives rose from 37,509 contracts to 43,682, an increase of 6,173 contracts or 16.46%. This expansion in OI was accompanied by a volume of 41,569 contracts, indicating robust trading activity. The futures segment alone accounted for a value of approximately ₹35,274 lakhs, while options contributed a staggering ₹38,543 crores in notional value, culminating in a total derivatives value of ₹40,450 lakhs. Such figures underscore heightened speculative interest and active positioning in the stock’s derivatives market.
Price Performance and Market Sentiment
Despite the surge in derivatives activity, Lupin’s underlying equity price underperformed, closing at ₹2,279, down 4.04% on the day. The stock opened with a gap down of 3.73% and touched an intraday low of ₹2,275.2, trading within a narrow range of just ₹1.7. Notably, the weighted average price skewed closer to the day’s low, suggesting selling pressure dominated the session. Over the past four consecutive sessions, Lupin has declined by 5.55%, underperforming its sector by 3.57% and the broader Sensex, which was marginally positive at 0.09%.
Technical Positioning and Moving Averages
From a technical standpoint, Lupin’s price remains above its 200-day moving average, a long-term bullish indicator. However, it is trading below its 5-day, 20-day, 50-day, and 100-day moving averages, signalling short- to medium-term weakness. This mixed technical picture suggests that while the stock retains some underlying strength, recent momentum has faltered, possibly prompting traders to hedge or reposition through derivatives.
Investor Participation and Liquidity
Investor participation appears to be waning, with delivery volumes on 7 Aug falling by 3.94% to 8.69 lakh shares compared to the five-day average. This decline in delivery volume indicates reduced conviction among long-term holders amid the recent price weakness. Nevertheless, liquidity remains adequate, with the stock’s traded value supporting sizeable trades up to ₹7.5 crore based on 2% of the five-day average traded value, ensuring that derivatives and cash market participants can execute sizeable positions without undue slippage.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
Interpreting the Open Interest Surge
The sharp increase in open interest amid falling prices typically suggests that new short positions are being initiated, or that existing longs are being hedged or closed. In Lupin’s case, the 16.46% rise in OI alongside a 4% price decline points to growing bearish bets or protective strategies by market participants. This is further supported by the volume concentration near the day’s low, indicating selling dominance.
Alternatively, some traders may be using options strategies to hedge exposure or speculate on volatility. The enormous notional value in options contracts (₹38,543 crores) relative to futures (₹35,274 lakhs) highlights the importance of options in shaping market sentiment and positioning. The disparity between the underlying’s price weakness and rising derivatives activity could also reflect expectations of a near-term rebound or volatility spike, prompting complex option plays such as straddles or spreads.
Mojo Score and Analyst Ratings
Lupin currently holds a Mojo Score of 74.0, categorised as a Buy rating, though this represents a downgrade from a previous Strong Buy grade assigned on 3 Aug 2026. This adjustment reflects the recent price underperformance and evolving risk profile. The mid-cap pharmaceutical company, with a market capitalisation of ₹1,04,855 crore, faces sector headwinds but retains fundamental strengths that support a cautiously optimistic outlook.
Sector and Market Context
The Pharmaceuticals & Biotechnology sector has shown mixed performance recently, with Lupin’s 1-day return of -3.63% lagging the sector’s modest decline of 0.19%. The broader Sensex’s slight gain of 0.09% underscores Lupin’s relative weakness. This divergence may be attributed to company-specific factors such as earnings concerns, regulatory developments, or competitive pressures, which are influencing investor sentiment and derivatives positioning.
Thinking about Lupin Ltd.? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this mid-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Implications for Investors and Traders
For investors, the recent price weakness combined with rising open interest suggests caution. The downgrade from Strong Buy to Buy signals a need to reassess risk exposure and monitor upcoming earnings or regulatory announcements closely. The falling delivery volumes indicate reduced conviction among long-term holders, which could exacerbate volatility in the near term.
Traders, meanwhile, may find opportunities in the derivatives market given the heightened activity and liquidity. The surge in open interest and volume points to increased speculative interest and potential for directional moves. Those with a bearish outlook might consider short futures or put options, while contrarian traders could watch for signs of short covering or volatility spikes that might trigger rebounds.
Conclusion
Lupin Ltd.’s derivatives market activity on 10 Aug 2026 reveals a complex interplay of bearish sentiment and strategic positioning. The 16.46% rise in open interest amid a 4% price decline highlights growing market interest in hedging or directional bets. While the stock remains above its long-term moving average, short-term technicals and falling investor participation suggest caution. Investors and traders should closely monitor volume patterns, open interest trends, and sector developments to navigate this evolving landscape effectively.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
